Ultravate® (halobetasol propionate) – Expanded indication
August 27, 2020 - The FDA approved Sun Pharmaceuticals’ Ultravate (halobetasol propionate) lotion, for the topical treatment of plaque psoriasis in patients twelve (12) years of age and older.
Download PDF
